Boosted- lopinavir versus boosted- atazanavir plus two nucleoside reverse transcriptase inhibitors in second- line antiretroviral therapy in HIV-1 infected patients in Abidjan, Ivory Coast
Journal Title: Journal of Microbiology and Infectious Diseases - Year 2016, Vol 6, Issue 4
Abstract
Introduction: Atazanavir is a protease inhibitor recently introduce in the therapeutic arsenal for second-line antiretroviral therapy in Ivory Coast. The objective of this study was to compare the efficacy and safety of a second-line treatment with 2 NRTIs + boosted lopinavir (LPV/r) versus 2 NRTIs + boosted atazanavir (ATV/r) in HIV-1 positive patients in Abidjan. Patients and Methods: Retrospective, comparative, single-center study, in 194 HIV-1 positive patients (143 with LPV/r, 51 with ATV/r), failed a first-line treatment, followed in Abidjan on 1 May 2009 to 30 June 2010. The analysis focused on clinical parameters and immuno-virological data. The principal judgement criterion was the proportion of patients with undetectable viral load in both groups after 12 months of HAART. Tolerance was found on the frequency of adverse events grade 3-4 during follow-up. Results: Clinically, improvement of the general condition and regression of opportunistic infections was similar in both groups. The average gain of CD4 after 12 months of follow-up was +357/mm3 in the LPV/r group versus +278 mm3 for ATV/r group (p = 0.012). The percentage of patients with undetectable viral load was similar in both groups (92% vs. 96% ; p = 0.535). The frequency of grade 3-4 adverse events was similar in both groups. Conclusion: HAART with LPV/r is at least as efficient as with ATV/r in second-line treatment, in terms of viral load reduction, with better recovery of CD4. LPV/r is an excellent second-line treatment in resource-limited countries. J Microbiol Infect Dis 2016;6(4): 149-155
Authors and Affiliations
Eboi Ehui, Alain N’douba Kassi, Gisèle Affoué Kouakou, Adama Doumbia, Chrysostome Melaine Mossou, Sinaly Kamagaté, Aristophane Koffi Tanon, Fréderic Nogbou Ello, Serge Eholié
Keywords
Related Articles
- EP ID EP412712
- DOI 10.5799/jmid.328859
- Views 107
- Downloads 0
In-vitro susceptibility of multiple drug resistant Pseudomonas aeruginosa to organic acids
Objectives: Pseudomonas aeruginosa is a classic opportunistic pathogen with innate resistance to many antibiotics and disinfectants. Resistance to antimicrobial agents makes it the most noxious organism to eliminate fro...
Anti-tüberküloz tedavisi alan ergen yaştaki bir kız çocuğunda kendiliğinden iyileşen hemofagositik sendrom
Enfeksiyon ilişkili hemofagositik sendrom (HPS) nadirdir ve potansiyel olarak ölümcül olabilir. Reaktif HPS, tüberküloz dâhil olmak üzere çeşitli enfeksiyonlarla birlikte bildirilmiştir. Tüberküloz ilişkili HPS erişkinle...
Nosocomial Infections in Very Low Birth Weight Infants: Etiology and Risk Factors
Objective: We aimed to find out the incidence and risk factors of nosocomial infections in VLBW neonates and to explore the microbiologic flora, sensitivity pattern and outcome. Methods: A prospective, observational stud...
Urged Nephrectomy in a Renal Transplant Recipient
Acute Urinary Tract Infection (UTI) not only affects a patient well-being but also gives rise to several issues like Interaction of antibiotics with immunosuppressive drugs, isolation of resistant strains, recurrent UTI,...
Van yöresinde gıda çalışanlarında Helicobacter pylori dışkı antijen feko-prevelansı
Amaç: Helicobacter pylori peptik ülser ve kanserin patogenezinde rol almakta, ayrıca ekstragastrik infeksiyonlara neden olabilmektedir. Bu bakteri infekte insanlar vasıtasıyla fekal-oral, oral-oral ve gastro-oral yolla b...